After Earnings, JP Morgan Chase and Co. (JPM) could be a Steal at the Current Price

Most analysts agree that financial stocks, and especially banks, will perform well this earnings season. In fact, with the exception of perhaps Bank of America Corp (NYSE:BAC), most of them have fared quite well. Some have been especially good, like Goldman Sachs Group, Inc. (NYSE:GS), which has blown it out of the park ($5.60 EPS versus the analyst consensus of $3.66 EPS). No wonder shares of Goldman have jumped more than 6% after the earnings report.  And, at a P/E of 10.23x, the stock is still far from unattractive.

JPMorgan Chase & Co (NYSE:JPM)There has been, however, another bank that has a good earnings report out, but it has been overlooked by the market: JPMorgan Chase & Co. (NYSE:JPM). On Jan. 21 the American bank reported net income of $5.7 billion (up from $3.7 billion last year), and EPS of $1.39, up from last year’s $0.90, beating the analyst estimates of $1.16 (that’s roughly a 20% beat). The stock, however, barely moved on the days that followed the report, which could signal that the market has overlooked this one.

But is the market wrong? How does JP Morgan’s stock look like?

  • It trades at 8.93x earnings, which is a very low valuation, even for financial stocks. Forward P/E is even lower (at only 8.09x). From a valuation perspective, the stock is very cheap.
  • It currently has an average target price of $51.29. That implies an upside potential of more than 10%.
  • The bank has posted record profits three years in a row.
  • They have successfully returned to safer business areas (such as mortgages and deposits), and yet are still a strong player in investment banking.
  • When compared to its main competitors, JPM has an edge:
Stock P/E Forward P/E Average Price Target Implied Upside from Avg PT Dividend Yield
JP Morgan 8.92 8.09 $51.29 10.51% 2.59%
Bank of America 44.56 8.70 $12 5.72% 0.36%
Goldman Sachs 10.20 9.78 $143.48 -1.24% 1.38%
Wells Fargo 10.40 8.98 $38.91 11% 2.52%

As one can see in the above table, JPM is more attractive than its main competitors in all areas except “Implied Upside from Average Price Target,” where Wells Fargo’s implied upside is very slightly above JP Morgan’s. With the exception of Bank of America’s current P/E, all stocks seem cheap, but JP Morgan is by far the cheapest of the lot.

What are insiders doing?

There seems to be some positive insider movement as well. On Jan. 29, JP Morgan Director Patrick Flynn bought 6,750 shares of the company, at $46.93 each, for a total value of roughly $320,000. This insider purchase might be a sign that company officials believe the stock is poised to outperform. However, just two days after on Jan 31, Managing Director Mary Erdoes sold 15,000 shares, so the insider picture is not as clear. No insider buying has been recorded in any of JPM’s main competitors in January, and yet there has been some insider selling this year going on at Goldman Sachs and Wells Fargo. At any rate, insider selling, unlike insider buying, is not as strong an indicator of how company officials see the their stock, so do not base an investing decision on this information alone.

Bottom Line

The market has not reacted to JP Morgan’s good earnings report. The bank has room to grow, trades at very low valuations, has an above-average dividend yield, and shows more than a 10% in implied upside when taking into account the analysts’ target price average. If an investor wants to go long on an American bank stock this year, I would definitely keep JPM in mind. With the economy recovering, and a strong bullish market forming, this stock will probably not be this cheap for too long.

The article After Earnings, this Bank Stock could be a Steal at the Current Price originally appeared on Fool.com and is written by Alex Bastardas.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!